EMAIL DETAILS
SUBJECT:
2011/2012 House CDMRP Numbers are "In"
PRI: NORMAL
FROM:
S
skip@zerocancer.org
DATE:
2011-06-14 15:36:20
MSG_ID:
<BANLkTi=ahDFVYvJSiOVEZy=QkLUKv0Grpw@mail.gmail.com>
RECIPIENTS:
TO:
H
Mr. Hunter Biden
<hbiden@rosemontseneca.com>
J
Sherry Galloway
<jersmom@rocketmail.com>
J
Mr. Jonathan Schwartz
<jschwartz@bellsouth.net>
J
Jill O'Donnell-Tormey
<jtormey@cancerresearch.org>
K
ken.griffey.sr@hotmail.com
M
Mr. Mitch Laurance
<mlonthegreen@aol.com>
M
Mr. Michael Milken
<mmilken@knowledgeu.com>
M
Mike Smith
<msmith@cgagroup.com>
R
Concepcion, Raoul S.
<rsconcepcion@ua-pc.com>
R
Mr. Robin Sparrow
<rsparrow@studley.com>
S
Sanford Siegel
<ssiegel585@gmail.com>
T
Dr. Thomas Moody
<tmoody@urologyal.com>
T
Mr. Tom Quinn
<tomquinn@sc.rr.com>
CC:
A
Anne Marie Person
<amperson@rosemontseneca.com>
B
Betsy London
<betsy@zerocancer.org>
J
Jamie Bearse
<jamie@zerocancer.org>
K
Kevin Johnson
<kevin@zerocancer.org>
K
Mr. Michael Milken
<kvantrease@knowledgeu.com>
S
Sherry Wilson
<swilson@urologyal.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
All, Here is the latest update from Kevin and his team. They are currently at the House mark-up. The numbers we have are for the House. We will have to see what the Senate does. Kevin reports, "Barring amendments that may or may not materialize today during the markup, here are the numbers. DOD Medical research – Pres Budget = $664m, Committee $1.2 (+523.5m over the President's budget, but 25% below adds from last year which totaled almost $700m) Breast Cancer Research - $150m in 2011, $120m in 2012 mark Prostate Cancer Research - $80m in 2011, $64m in 2012 mark Ovarian Cancer Research - $20m in 2011, $16m in 2012 mark Overall CDMRP funding cut by 20%." Kevin succinctly summarized today's actions thusly, "the House Appropriations Committee approved a bill that would provide $64 million in FY2012 for the Prostate Cancer Research Program as part of the Congressionally Directed Medical Research Program. This marks a 20% reduction from the $80 million provided in FY2011." As a reminder we still have to go through the Senate process and the final reconciliation process if there are significant difference between the House and Senate versions. Kevin will be providing all of you with a more nuanced assessment of the proceedings once the mark-up is complete. Given the overwhelming focus on cutting spending, especially in the House, it is a testament to Kevin and David's day-to-day perserverance on Cap. Hill as well as their collaborative work with the CDMRP community that these programs were not eliminated completely. I also want to thank the Members of the Board that have gone out of their way to make sure that Congress understands the full importance of the CDMRP program. Make no mistake though, these cuts will cost American men their lives as promising new treatments for prostate cancer will take much longer to develop and to migrate from research to the patient. --Skip -- Skip Lockwood President and CEO ZERO -- The Project to End Prostate Cancer 10 G St., NE Suite 601 Washington, DC 20002 202-463-9455 (main) 202-463-9456 (fax) Virginia Office: 515 King St. Suite 420 Alexandria, VA 22304 www.zerocancer.org Twitter: www.twitter.com/digitalskip Facebook: ZERO — The Project to End Prostate Cancer Combined Federal Campaign #12161 ______________________________________
METADATA:
THREAD:
INDEX:
AdhhpFudNIBnmtwjROiP60eEOTENSg==